共 224 条
[1]
Wieacker P(2010)The prenatal diagnosis of genetic diseases Dtsch. Arztebl. Int. 107 857-862
[2]
Steinhard J(2016)Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis J. Matern. Fetal. Neonatal Med. 29 1160-1164
[3]
Fairbrother G(1988)Maternal serum screening for Down’s syndrome in early pregnancy BMJ 297 883-887
[4]
Burigo J(2008)Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet. Gynecol. 31 618-624
[5]
Sharon T(2014)A cost-effectiveness analysis comparing different strategies to implement noninvasive prenatal testing into a down syndrome screening program Aust. New Zeal. J. Obstet. Gynaecol. 54 412-417
[6]
Song K(2014)The consequences of implementing non-invasive prenatal testing in Dutch national health care: a cost-effectiveness analysis Eur. J. Obstet. Gynecol. Reprod. Biol. 182 53-61
[7]
Wald NJ(2014)Model-based analysis of costs and outcomes of non-invasive prenatal testing for Down’s syndrome using cell free fetal DNA in the UK National Health Service PLoS One 9 e93559-126
[8]
Cuckle HS(2015)Non-invasive prenatal testing: a review of international implementation and challenges Int. J. Womens. Health. 7 113-967
[9]
Densem JW(2015)Global perspectives on clinical adoption of NIPT Prenat. Diagn. 35 959-433
[10]
Nanchahal K(2014)Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis Ultrasound Obstet. Gynecol. 53 425-1137